| Autor: |
Sautenet, Bénédicte, Cho, Yeoungjee, Gutman, Talia, Rangan, Gopala, Ong, Albert, Chapman, Arlene B., Ahn, Curie, Coolican, Helen, Tze-Wah Kao, Juliana, Fowler, Kevin, Gansevoort, Ron T., Geneste, Claire, Perrone, Ronald D., Harris, Tess, Torres, Vicente E., Pei, York, Craig, Jonathan C., Tong, Allison, Rangan, Gopala, Ong, Albert, Chapman, Arlene, Ahn, Curie, Coolican, Helen, Tze-Wah Kao, Juliana, Fowler, Kevin, Gansevoort, Ron, Perrone, Ronald, Harris, Tess, Torres, Vicente, Pei, York, Cho, Yeoungjee, Gutman, Talia, Sautenet, Benedicte |
| Zdroj: |
American Journal of Kidney Diseases; August 2020, Vol. 76 Issue: 2 p213-223, 11p |
| Abstrakt: |
Trials in autosomal dominant polycystic kidney disease (ADPKD) have increased, but their impact on decision making has been limited. Because heterogeneity in reported outcomes may be responsible, we assessed their range and variability in ADPKD trials. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
